Clinical Trial Update: BCG and Plasma Amyloid in Non-Demented Adults [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating BCG and plasma amyloid in adults with late-onset Alzheimer disease; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease Late-onset

Drugs mentioned

• BCG (Bacillus Calmette-Guérin)
• Plasma amyloid (plasma amyloid)

Snippet

Sponsor: Mindful Diagnostics and Therapeutics, LLC | Conditions: Alzheimer Disease, Late Onset | Phase 2 | Status: COMPLETED